Rolipram versus lmipramine in Inpatients with Major, “Minor” or Atypical Depressive Disorder: A Double-Blind Double-Dummy Study Aimed at Testing a Novel Therapeutic Approach


    loading  Checking for direct PDF access through Ovid

Abstract

Unlike conventional antidepressants, rolipram stimulates both the presynaptic as well as the postsynaptic component of monoaminergic transmisson. Several double-blind comparative trials are on the way to assess the clinical efficacy and safety of this novel compound.The present study was a randomized double-blind double-dummy comparison with imipramine in inpatients with major. “minor” and atypical depressions (DSM III). Results show no relevant differences between rolipram and imipramine regarding efficacy and safety.

    loading  Loading Related Articles